Quarterly ResultAug 6, 2026, 04:23 PM
SkinHealth Systems Q2 Net Sales Down 7.8% to $72.1M; Reports Net Loss
AI Summary
SkinHealth Systems reported Q2 2026 net sales of $72.1 million, a 7.8% decrease year-over-year, and a net loss of $(2.7) million. Despite sales pressure, the company achieved an adjusted EBITDA of $17.0 million, exceeding guidance, driven by improved gross margin and disciplined operating expense management. The company also revised its full-year 2026 financial guidance downwards, reflecting continued sales pressure while maintaining cost discipline.
Key Highlights
- Q2 2026 net sales decreased 7.8% to $72.1 million from $78.2 million in Q2 2025.
- Reported a net loss of $(2.7) million in Q2 2026, compared to net income of $19.7 million in Q2 2025.
- Adjusted EBITDA increased to $17.0 million in Q2 2026 from $13.9 million in Q2 2025.
- Gross margin improved to 68.4% in Q2 2026 from 62.8% in Q2 2025.
- Revised full-year 2026 net sales guidance to $280-$290 million.
- Revised full-year 2026 Adjusted EBITDA guidance to $39-$46 million.
- Total delivery systems sold decreased to 770 units in Q2 2026 from 957 units in Q2 2025.
- Consumables net sales were $53.9 million in Q2 2026, down from $55.8 million in Q2 2025.
Price Impact
More from SKIN